Clinical Trials on Intracellular Signaling Peptides and Proteins in Canada
Total 410 results
-
Spark TherapeuticsActive, not recruitingHemophilia AUnited States, Canada, Australia
-
Swedish Orphan BiovitrumBioverativ Therapeutics Inc.CompletedHemophilia AIreland, United Kingdom, Germany, United States, Canada, Slovenia, Sweden
-
University Health Network, TorontoCelgene Corporation; Otsuka Pharmaceutical Development & Commercialization,... and other collaboratorsCompleted
-
GlaxoSmithKlineCompletedMultiple MyelomaUnited States, Canada, United Kingdom
-
Canadian Myeloma Research GroupCompleted
-
ORIC PharmaceuticalsRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Canada, Puerto Rico
-
CRISPR Therapeutics AGActive, not recruitingMultiple MyelomaUnited States, Spain, Australia, Canada
-
CSL BehringCompletedCongenital Fibrinogen DeficiencyUnited States, Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompleted
-
Fundacion Para La Investigacion Hospital La FeUnknown
-
GlaxoSmithKlineMerck Sharp & Dohme LLCCompletedMultiple MyelomaSpain, Germany, United States, Canada
-
Merck Sharp & Dohme LLCCompletedHIV Infections | Hemophilia ACanada, United States
-
PfizerRecruitingMultiple MyelomaCanada, France, Japan, Australia, United States
-
CARsgen Therapeutics Co., Ltd.Active, not recruitingMultiple MyelomaUnited States, Canada
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada
-
CelgeneActive, not recruitingMultiple MyelomaSpain, Canada, United States
-
Genzyme, a Sanofi CompanyActive, not recruitingHemophiliaCanada, Italy, Turkey, Spain, United States, India
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaCanada, Germany
-
BayerCompletedBlood Coagulation Disorders | Hematologic DiseaseUnited States, Germany, United Kingdom, Canada
-
OctapharmaCompletedSevere Hemophilia AUnited States, France, Canada, United Kingdom, India, Georgia, Moldova, Republic of, Poland, Ukraine
-
Genentech, Inc.CompletedMultiple MyelomaUnited States, Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMultiple MyelomaUnited States, Canada
-
rEVO BiologicsCompletedAntithrombin III DeficiencyUnited States, France, United Kingdom, Germany, Canada, Austria, Australia, Italy
-
Millennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Advanced Solid TumorsUnited States, Canada
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
Spark TherapeuticsCompletedHemophilia AUnited States, Australia, Canada, Israel, Thailand
-
PfizerActive, not recruitingHemophilia BUnited States, Canada, Australia, Turkey
-
CSL BehringCompletedEmphysema | Alpha 1-proteinase Inhibitor DeficiencyAustralia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
-
Baxalta now part of ShireCompletedAcquired Hemophilia AUnited States, Canada, India, United Kingdom
-
NovartisCompletedMultiple MyelomaCanada, United States, Australia, Taiwan, Ireland
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Recruiting
-
Kedrion S.p.A.CompletedPrimary Immunodeficiency | Hypogammaglobulinemia | Agammaglobulinemia | Antibody DeficiencyUnited States, Canada
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
Baxalta now part of ShireBaxter Innovations GmbHTerminatedHemophilia APoland, United States, Bulgaria, Serbia, Canada, Russian Federation, Germany, Netherlands, Lithuania, Czechia, Austria, Spain
-
Bristol-Myers SquibbRecruitingMultiple MyelomaNorway, United States, Spain, United Kingdom, Canada
-
ModernaTX, Inc.WithdrawnRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States, Canada
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma (RRMM)United States, Canada
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited Kingdom, Spain, Canada, United States, Czechia
-
CelgeneCompletedMultiple Myeloma | Renal ImpairmentUnited States, Canada
-
PfizerCompletedHemophilia BCanada, Singapore, Turkey, Croatia, Korea, Republic of, Mexico, Poland, Bulgaria, Malaysia
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnLymphomaUnited States, Australia, United Kingdom, Canada, France
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Germany, Netherlands, Spain
-
PETHEMA FoundationJanssen, LP; Adknoma Health ResearchRecruitingMultiple Myeloma | Non-eligible for Autologous Stem Cell Transplantation (ASCT)Spain
-
Genentech, Inc.RecruitingMultiple MyelomaUnited States, Canada, Spain, Australia
-
European Society for Blood and Marrow TransplantationCompletedMultiple MyelomaAustria, Denmark, Germany, Finland, Canada, Sweden, Norway, France, Italy, United Kingdom, Turkey
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Italy, Canada, France, Germany, Netherlands, Spain